FNFDCM
PFE icon

Folger Nolan Fleming Douglas Capital Management’s Pfizer PFE Stock Holding History

Folger Nolan Fleming Douglas Capital Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$371K Sell
15,390
-400
-3% -$10.5K 0.03% 143
2026
Q1 		$443K Sell
15,790
-201
-1% -$5.35K 0.04% 129
2025
Q4 		$398K Sell
15,991
-500
-3% -$12.6K 0.04% 126
2025
Q3 		$420K Sell
16,491
-697
-4% -$17.2K 0.04% 125
2025
Q2 		$417K Sell
17,188
-4,687
-21% -$109K 0.05% 124
2025
Q1 		$554K Sell
21,875
-1,518
-6% -$39.7K 0.06% 107
2024
Q4 		$621K Sell
23,393
-2,404
-9% -$65.2K 0.07% 103
2024
Q3 		$747K Sell
25,797
-1,654
-6% -$48.2K 0.07% 100
2024
Q2 		$768K Sell
27,451
-923
-3% -$25.4K 0.08% 94
2024
Q1 		$787K Sell
28,374
-1,727
-6% -$47.9K 0.08% 96
2023
Q4 		$867K Sell
30,101
-2,824
-9% -$85.4K 0.09% 88
2023
Q3 		$1.09M Sell
32,925
-1,451
-4% -$51.3K 0.13% 80
2023
Q2 		$1.26M Sell
34,376
-1,483
-4% -$57.7K 0.14% 78
2023
Q1 		$1.46M Sell
35,859
-3,273
-8% -$141K 0.17% 69
2022
Q4 		$2M Buy
39,132
+8,809
+29% +$422K 0.24% 59
2022
Q3 		$1.33M Buy
30,323
+2,360
+8% +$115K 0.18% 66
2022
Q2 		$1.47M Sell
27,963
-1,080
-4% -$55K 0.19% 66
2022
Q1 		$1.5M Sell
29,043
-857
-3% -$44.5K 0.17% 70
2021
Q4 		$1.77M Sell
29,900
-2,245
-7% -$111K 0.19% 68
2021
Q3 		$1.38M Sell
32,145
-150
-0.5% -$6.64K 0.17% 73
2021
Q2 		$1.26M Sell
32,295
-1,754
-5% -$68.2K 0.15% 78
2021
Q1 		$1.23M Sell
34,049
-3,250
-9% -$115K 0.15% 81
2020
Q4 		$1.37M Sell
37,299
-1,641
-4% -$60.2K 0.18% 66
2020
Q3 		$1.36M Hold
38,940
– – 0.2% 66
2020
Q2 		$1.21M Sell
38,940
-563
-1% -$19.1K 0.2% 67
2020
Q1 		$1.22M Sell
39,503
-45
-0.1% -$1.53K 0.24% 66
2019
Q4 		$1.47M Hold
39,548
– – 0.21% 68
2019
Q3 		$1.35M Buy
39,548
+292
+0.7% +$10.6K 0.21% 69
2019
Q2 		$1.61M Sell
39,256
-211
-0.5% -$8.38K 0.24% 64
2019
Q1 		$1.59M Sell
39,467
-211
-0.5% -$8.45K 0.24% 62
2018
Q4 		$1.64M Sell
39,678
-263
-0.7% -$10.9K 0.27% 62
2018
Q3 		$1.67M Sell
39,941
-591
-1% -$22.8K 0.24% 62
2018
Q2 		$1.4M Sell
40,532
-195
-0.5% -$6.66K 0.2% 63
2018
Q1 		$1.37M Hold
40,727
– – 0.2% 64
2017
Q4 		$1.4M Buy
40,727
+2,000
+5% +$68.2K 0.2% 65
2017
Q3 		$1.31M Sell
38,727
-1,002
-3% -$32.2K 0.19% 66
2017
Q2 		$1.27M Sell
39,729
-106
-0.3% -$3.34K 0.19% 67
2017
Q1 		$1.29M Sell
39,835
-495
-1% -$15.6K 0.19% 68
2016
Q4 		$1.41M Hold
40,330
– – 0.23% 70
2016
Q3 		$1.41M Buy
40,330
+106
+0.3% +$3.54K 0.23% 70
2016
Q2 		$1.34M Sell
40,224
-316
-0.8% -$10.1K 0.23% 69
2016
Q1 		$1.14M Sell
40,540
-86
-0.2% -$2.46K 0.2% 71
2015
Q4 		$1.24M Sell
40,626
-1,971
-5% -$62K 0.22% 70
2015
Q3 		$1.27M Hold
42,597
– – 0.26% 70
2015
Q2 		$1.35M Hold
42,597
– – 0.25% 68
2015
Q1 		$1.41M Hold
42,597
– – 0.25% 70
2014
Q4 		$1.26M Sell
42,597
-907
-2% -$26K 0.22% 72
2014
Q3 		$1.22M Sell
43,504
-843
-2% -$23.7K 0.22% 72
2014
Q2 		$1.25M Sell
44,347
-211
-0.5% -$6.01K 0.23% 73
2014
Q1 		$1.36M Sell
44,558
-8,895
-17% -$265K 0.28% 67
2013
Q4 		$1.55M Sell
53,453
-471
-0.9% -$13.7K 0.27% 63
2013
Q3 		$1.47M Buy
53,924
+16,655
+45% +$453K 0.28% 61
2013
Q2 		$990K Buy
+37,269
New +$1.03M 0.21% 74

Other funds holding PFE

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
CWP
Curated Wealth Partners El Segundo, California $774M AUM 5.71% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
FWIA
Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return
ORIO
Old Republic International (ORI) Chicago, Illinois $2.67B AUM 26.94% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return
KC
Kepler Cheuvreux Nyon $1.75B AUM 37.37% 1-Year Est. Return
WAM
Wilsey Asset Management San Diego, California $681M AUM 6.7% 1-Year Est. Return

Folger Nolan Fleming Douglas Capital Management's PFE Position: Q2 2026 in Review

Folger Nolan Fleming Douglas Capital Management reduced its Pfizer (PFE) stake by 2.5% in Q2 2026, selling an estimated $10.5K and leaving 15,390 shares worth $371K. The position accounts for 0.03% of the portfolio, ranked #143.

Folger Nolan Fleming Douglas Capital Management first reported a position in PFE in Q2 2013 and has held it in 53 quarters since. The position peaked at $2M in Q4 2022. 557 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Folger Nolan Fleming Douglas Capital Management held 15,390 shares of Pfizer worth $371K as of Q2 2026.
  • Folger Nolan Fleming Douglas Capital Management sold 400 Pfizer shares in Q2 2026, an estimated $10.5K.
  • Pfizer made up 0.03% of Folger Nolan Fleming Douglas Capital Management's portfolio in Q2 2026, its #143 holding.
  • Folger Nolan Fleming Douglas Capital Management first reported a position in Pfizer in Q2 2013 and has held it in 53 quarters since.
  • Folger Nolan Fleming Douglas Capital Management's Pfizer position peaked at $2M in Q4 2022.
  • 557 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Folger Nolan Fleming Douglas Capital Management's 13F filing for Q2 2026, filed 16 Jul 2026.